# Globus Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/globus-medical

- Industry: Medical Devices & Equipment
- Headquarters: Audubon, US
- Website: www.globusmedical.com
- Total disclosed funding: $110M
- Latest round: Series E (Aug 23, 2007)
- Investors on record: 3

## About

Globus Medical, Inc. is a medical technology firm focused on innovative musculoskeletal solutions, enhancing surgical procedures with advanced technologies in spine and orthopedic care.Founded in 2003 in Audubon, US, Globus Medical, Inc. specializes in musculoskeletal solutions, with no significant business pivots noted. The company operates independently without a parent or subsidiary relationship. The firm was established by Narmada Ramakrishna, who has a history in the medical technology sector. Globus Medical raised USD 99.6 mn in its IPO in August 2012, successfully amending its offering terms shortly before the sale.Globus Medical specializes in innovative musculoskeletal solutions, primarily focused on enhancing surgical procedures through advanced technology. Their core product offerings include the Excelsius™ Technology ecosystem, which integrates robotic navigation and imaging systems to improve safety and efficiency in the operating room. The company’s spine procedure portfolio encompasses various solutions, including interbody spacers, fixation systems, and regenerative biologics tailored for diverse surgical techniques. Globus Medical also addresses orthopedic trauma through nailing and plating systems, alongside their joint reconstruction solutions for hip and knee surgeries, emphasizing patient care and clinical outcomes. Their products are utilized by healthcare professionals across multiple geographical markets, including the United States, Europe, and parts of Asia, where they serve hospitals, surgical centers, and orthopedic clinics.In 2024, Globus Medical reported revenue of USD 2,519,355 and an EBITDA of USD 420,015. The company's revenue generation relies on direct sales to healthcare providers, hospitals, and surgical centers within the musculoskeletal sector, featuring a mixture of transaction structures. Globus Medical engages in B2B sales relationships, providing its surgical products and services through direct channels rather than retail or wholesale partnerships. Flagship products, such as the ExcelsiusGPS™ robotic navigation system and the XLIF™ minimally invasive spine surgical technique, are pivotal in their sales strategy, which involves bulk purchases and ongoing service agreements to ensure optimal usage and support. Their pricing structure is designed to accommodate the varying needs of their client base, aligning with the advanced technologies and innovative solutions provided, with transactions typically tailored to the specific requirements of each healthcare facility.Globus Medical plans to leverage the proceeds from its IPO to support the development of new products and expansion into new markets. The company is aiming to innovate its product line, particularly focusing on enhancements to the Excelsius™ Technology ecosystem, with anticipated launches in the near future. Additionally, Globus Medical seeks to penetrate further into European and Asian healthcare markets by the end of 2025, increasing its global footprint. The successful IPO, raising USD 99.6 mn, will facilitate these initiatives and help broaden their operational capabilities.

## Funding rounds

- Series E, Aug 23, 2007, $110M — Clarus Ventures, Goldman Sachs Asset Management, SunAmerica Ventures

## Investors

- Clarus Ventures (https://capitalatlas.ai/funds/clarus-ventures) — Series E
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series E
- SunAmerica Ventures — Series E